Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs
暂无分享,去创建一个
A. Tonevitsky | D. Sakharov | A. Belyy | S. Deyev | A. Belogurov | A. Gabibov | V. Tsetlin | I. Dyachenko | M. Dronina | I. Kasheverov | V. Knorre | A. Stepanov | A. Murashev | N. Ponomarenko | A. Rybinets
[1] S. Kaveri,et al. Specific Depletion of Myelin-Reactive B Cells via BCR-Targeting , 2015, Acta naturae.
[2] S. Zamvil,et al. Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets , 2015, European Neurology.
[3] E. N. Lebedenko,et al. Man-made antibodies and immunoconjugates with desired properties: function optimization using structural engineering , 2015 .
[4] M. Dubina,et al. Liposome-encapsulated peptides protect against experimental allergic encephalitis , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] M. Krumbholz,et al. B cells and antibodies in multiple sclerosis pathogenesis and therapy , 2012, Nature Reviews Neurology.
[6] A. Tonevitsky,et al. Design of Targeted B Cell Killing Agents , 2011, PloS one.
[7] P. Sørensen,et al. The changing demographic pattern of multiple sclerosis epidemiology , 2010, The Lancet Neurology.
[8] A. Kozyr,et al. Catalytic antibodies: balancing between Dr. Jekyll and Mr. Hyde , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.
[9] R. Fischer,et al. Depletion of autoreactive B-lymphocytes by a recombinant myelin oligodendrocyte glycoprotein-based immunotoxin , 2008, Journal of Neuroimmunology.
[10] M. Wilm,et al. Legionella pneumophila glucosyltransferase inhibits host elongation factor 1A , 2006, Proceedings of the National Academy of Sciences.
[11] A. Lutterotti,et al. Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments , 2006, Journal of Neuroimmunology.
[12] P. Baeuerle,et al. Specific depletion of autoreactive B lymphocytes by a recombinant fusion protein in vitro and in vivo. , 2003, International immunology.
[13] M. Reindl,et al. Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis , 2001, Multiple sclerosis.
[14] Ira Pastan,et al. Immunotoxin therapy of cancer. , 1993, Nature reviews. Cancer.
[15] D. Hafler,et al. Multiple sclerosis. , 2012, The Journal of clinical investigation.